Does Rallies show Form 4 insider transactions for SXTP?

Yes. Rallies tracks SXTP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is SXTP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SXTP. It does not provide personalized investment advice.

SXTP (60 Degrees Pharmaceuticals, Inc. Common Stock) Stock Analysis - Insider Trades

60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) is a publicly traded Healthcare sector company. As of May 21, 2026, SXTP trades at $1.38 with a market cap of $3.80M and a P/E ratio of -0.12. SXTP moved -1.42% today. Year to date, SXTP is -28.86%; over the trailing twelve months it is -85.23%. Its 52-week range spans $1.29 to $49.80. Analyst consensus is buy with an average price target of $14.10. Rallies surfaces SXTP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading SXTP stock inside the company?

Recent SXTP insider activity includes DOW GEOFFREY S bought 9.67K, DOW GEOFFREY S bought 3.61K, DOW GEOFFREY S bought 9.35K, XU CHERYL bought 3.00K, and XU CHERYL bought 2.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

SXTP Key Metrics

Key financial metrics for SXTP
Metric	Value
Price	$1.38
Market Cap	$3.80M
P/E Ratio	-0.12
EPS	$-11.73
Dividend Yield	0.00%
52-Week High	$49.80
52-Week Low	$1.29
Volume	1.47K
Avg Volume	0
Revenue (TTM)	$1.01M
Net Income	$-7.37M
Gross Margin	22.26%

Recent SXTP Insider Trades

DOW GEOFFREY S bought 9.67K (~$7.76K) on Dec 15, 2025.
DOW GEOFFREY S bought 3.61K (~$3.32K) on Dec 11, 2025.
DOW GEOFFREY S bought 9.35K (~$8.89K) on Dec 10, 2025.
XU CHERYL bought 3.00K (~$8.61K) on Jun 3, 2025.
XU CHERYL bought 2.00K (~$5.80K) on Jun 3, 2025.

Latest SXTP News

60 Degrees Pharma Launches Weekly ARAKODA Malaria Prevention on Runway Health — Apr 15, 2026
60 Degrees Pharma Posts 65% Revenue Surge, Narrows Net Loss to $7.37M — Mar 31, 2026
60 Degrees Reports 100% Cure in Relapsing Babesiosis Trial, Calls Guideline Review — Mar 11, 2026

SXTP Analyst Consensus

2 analysts cover SXTP: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.10.

Common questions about SXTP

Who is trading SXTP stock inside the company?: Recent SXTP insider activity includes DOW GEOFFREY S bought 9.67K, DOW GEOFFREY S bought 3.61K, DOW GEOFFREY S bought 9.35K, XU CHERYL bought 3.00K, and XU CHERYL bought 2.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for SXTP?: Yes. Rallies tracks SXTP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is SXTP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SXTP. It does not provide personalized investment advice.